You searched for "medication"
Screening for hearing loss in primary care
Hearing impairment is one physical disability that is increasing in prevalence in society in general, and in older adults in particular. Approximately 34 to 36 million Americans report suffering from some degree of hearing impairment with the number rising to...Hearing, tinnitus and hyperacusis in the arts
Hearing loss, tinnitus and hyperacusis are discussed by David Baguley from the unique perspective of their depictions in literature, music, film and paintings. This article provides unusual and invaluable reflective opportunities for the patient-centred clinician! Audiologists and otologists understand hearing...Unanswered questions in adult ototoxicity associated with platinum-based chemotherapy
Do the potential side-effects on hearing and tinnitus need to be a ‘necessary evil’ of platinum-based chemotherapy? How strong is our evidence base when offering advice to patients and fellow clinicians? David Baguley and his team from the University of...The pioneer of precision: Wolfgang Steiner and the evolution of transoral laser surgery
It is rare that a single clinician entirely changes the course of the management of a particular condition. Steiner was one such clinician. Wolfgang Steiner was to transoral laser microsurgery what Grandmaster Flash was to hip-hop or James Brown was...In conversation with Professor Eugene Myers: My life in ENT
In a series of interviews, former Chairman of the Editorial Board for ENT & audiology news, Professor Patrick J Bradley, speaks with eminent otolaryngologists who have retired (or are about to retire) from practice. Our first is with Professor Gene...
Coblation versus microdebrider submucosal inferior turbinoplasty
This prospective randomised study from Riyadh compares submucosal coblation and submucosal microdebrider inferior turbinate reduction. Seventy patients were recruited who had failed medical treatment and were undergoing isolated inferior turbinate surgery. Outcome measures included the Friedman score and VAS for...Hong Kong Auditory Science Meeting 2025
Yuan Chen, Assistant Professor in the Department of Special Education and Counselling, The Education University of Hong Kong.Organised by the Clinical Hearing Sciences (CHearS) Laboratory and supported by the University Grants Committee and the Faculty of Education at the University...
Paranasal sinus osteoma management
The authors aimed to determine the best approach to paranasal osteoma excision. They conducted a retrospective study of 41 patients with paranasal sinus osteoma (PNSO) at a tertiary centre in Turkey. PNSO was present in: the frontal sinus in 26...
Do you use the evidence or do you just know to do that?
In this day and age we generally consider healthcare practice to be evidence-based. Unfortunately there are not always the plethora of research articles available that address the dilemmas of day-to-day clinical practice. This piece of work considers what factors influence...
Grading dysphagia as a toxicity in treating head and neck cancer
Common Terminology Criteria for Adverse Events (CTCAE) is a system used by clinicians to grade the toxicity of oncology treatments in a standardised manner. Dysphagia is perhaps the most common long-term toxicity of head and neck cancer treatment. Currently, a...
High dose betahistine as effective as, but slower acting compared to intratympanic dexamethasone in intractable Meniere’s disease
The management of intractable Meniere’s disease poses a complex conundrum to otolaryngologists. The focus of treatment is decreasing the severity and frequency of vertigo and tinnitus whilst trying to preserve hearing. Betahistine has been used for many years in the...
